Endoxifen and fulvestrant regulate estrogen-receptor α and related DEADbox proteins

Endoxifen and fulvestrant regulate estrogen-receptor α and related DEADbox proteins

Breast cancer (BC) represents the most common type of cancer in females worldwide. Endocrine therapy evolved as one of the main concepts in treatment of hormone-receptor positive BC. Current research focuses on the elucidation of tumour resistance mechanisms against endocrine therapy. In a translati...

Full description

Bibliographic Details
Main Authors: Jasmin Asberger, Thalia Erbes, Markus Jaeger, Gerta Rücker, Claudia Nöthling, Andrea Ritter, Kai Berner, Ingolf Juhasz-Böss, Marc Hirschfeld
Format: Article
Language:English
Published: Bioscientifica 2020-12-01
Series:Endocrine Connections
Subjects:
ddx1
ddx5
ddx17
breast cancer
endocrine therapy
Online Access:https://ec.bioscientifica.com/view/journals/ec/9/12/EC-20-0281.xml

Internet

https://ec.bioscientifica.com/view/journals/ec/9/12/EC-20-0281.xml

Similar Items